Mmimetika ApS: Financial statements 2024
CVR: 43340743
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Mmimetika ApS (CVR 43340743) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 714,369 and a net result of DKK 521,268 compared with DKK -59,189 the year before. That is an increase of 1,616.9% compared with the year before. Equity in the 2024 report amounted to DKK 5,989,670. The solvency ratio was 89.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 714,369
- Profit/Loss
- DKK 521,268
- Equity
- DKK 5,989,670
- Total Assets
- DKK 6,685,418
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 714 t. | 521 t. | 6 mio. | 3 |
| 2023 | - | 42 t. | -59 t. | 5.5 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Mmimetika ApS has published its annual report for 2023. Gross profit came to DKK 41,608, and the net result was DKK -59,189.
About Mmimetika ApS
Mmimetika ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named KetLace Biosciences ApS. The management consists of Karan Sarin. The board consists of Jakob Helding Rasmussen (chair), Allan Møller Rasmussen, Jens Christian Klibo and Mogens Johannsen. The company's owners include SEYDLITZ GRUPPEN ApS, Mousing Holding ApS and Thomas B. Poulsen Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 713,232 and a net result of DKK 256,210 compared with DKK 521,268 the year before. Equity in the 2025 report amounted to DKK 6,245,880.